CA19-9 represents the most important and basic carbohydrate tumor marker. The immunohistologic distribution of CA19-9 in tissues is consistent with the quantitative determination of higher CA19-9 concentrations in cancer than in normal or inflamed tissues. Recently reports indicates that the serum CA19-9 level is frequently elevated in the serum of subjects with various gastrointestinal malignancies, such as pancreatic, colorectal, gastric and hepatic carcinomas. Together with CEA, elevated CA19-9 is suggestive of gallbladder neoplasm in the setting of inflammatory gallbladder disease. It has been shown that a persistent elevation in serumCA19-9 value following treatment may be indicative of occult metastatic and/or residual disease. A pers
Size
100 assays
Concentration
n/a
Applications
This ELISA kit is used for quantitative determination of CA19-9
Other Names
Carbohydrate Antigen 19-9 (human) ELISA Kit, Cancer Antigen 19-9 (human) ELISA Kit, Sialylated Lewis (a) Antigen (human) ELISA Kit